Editing
Synthesis of CBA-PolyAmines
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Synthesis<br> == Dissolve SP (0.202g, 1 mmol) and Dde-OH (0.419 g, 2.3 mmol) in 1 mL MeOH, stirring at room temperature for 24 h to let Dde group specifically protect primary amine groups in spermine.<br> The next day, add CBA (0.260g, 1 mmol) into above system in 1.5 mL of MeOH/diH 2 O (9/1 v/v). <br> Polymerize at 60° C in the dark under nitrogen atmosphere for 3-4 days.<br> Add 10% mol excess EDA to consume any unreacted acrylamide groups, stirring at 60°C for at least additional 2 h. <br> Precipitate polymer in 40 mL anhydrous diethyl ether to get the intermediate polymer poly(CBA-SP-Dde). <br> Remove the Dde groups in the deprotection mixture of NH2OH·HCl/Imidazole/NMP/DMF by stirring at room temperature for 4 h. <br> '''To make deprotection mixture: '''<br> 1.25 g (1.80 mmol) of NH2OH·HCl <br> 0.918 g (1.35 mmol) of imidazole is suspended in 5 mL of NMP. <br> Sonicate the mixture until complete dissolution. <br> Just before reaction, dilute 5 volume of this solution with 1 volume of DMF to make the deprotection mixture. <br> After deprotection, purify the crude product by dialysis (MWCO = 1000) against MilliQ water for 24 h<br> Dry by lypholization to obtain poly(CBA-SP) as solid gel.<br> <br> [[Image:Polyamine CBA synthesis.png|600px|Polyamine CBA synthesis.png]]<br> [[Image:Polyamine CBA cytotoxicity.png|600px|Polyamine CBA cytotoxicity.png]]<br> [[Image:Polyamine CBA TR efficiency.png]]<br> poly(CBA-TETA) and poly(CBA-AEPD)is the best for uptake<br> but poly(CBA-SP), poly(CBA-APPD) and poly(CBA-APED) have higher transfection efficiency<br> for cost + efficiency: use poly(CBA-APED)<br> <br>
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages